Broadening theimpact of genomics
At Helix, we’re dedicated to making DNA learning accessible and actionable for everyone.
A population-scale impact
We are the leading population genomics company operating at the intersection of clinical care, research, and genomics. Our end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and both basic and translational research.
The fight against COVID-19
In response to the ongoing COVID-19 pandemic, we've developed a highly automated COVID-19 test system that includes one of the first Next Generation Sequencing assays to receive Emergency Use Authorization from the FDA. With funding from the NIH's Rapid Acceleration of Diagnostics program (RADx), we'll soon be processing up to 100,000 tests a day, making us one of the nation's largest COVID-19 testing laboratories.
What we value
It’s our mission to empower every person to improve their life through DNA. We believe in a world where everyone benefits from their biological information and is able to help all of humanity lead better lives.
From acclaimed venture capital firms to the leading sequencing company in the world, Helix is backed by the very best.
The people behind Helix
We’re a curious and passionate bunch. We think big but start small, collaborating on every level and across every department. We’re continually inspired by the enthusiasm of our in-house scientists but know you don’t need a PhD to geek out on genomics.Meet the team
Scientific advisory board
Our advisory board is composed of some of the world’s foremost experts in genomics. Each member serves an important role in upholding our high scientific standards and serves as a strategic resource as we build an ongoing destination for DNA discovery.Meet our scientific advisory board